Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Religious coping, like prayer, may protect against Alzheimer's disease (AD) by reducing brain tau pathology and improving memory in individuals with a genetic predisposition to AD.
Area Of Science
- Neuroscience
- Psychology
- Genetics
Background
- Stress is a known risk factor for Alzheimer's disease (AD).
- Religious stress coping practices, such as prayer and religious services, may offer protective benefits.
- Autosomal dominant AD provides a unique model to study early AD pathology and cognitive decline.
Purpose Of The Study
- To investigate the relationship between religious stress coping and memory performance in cognitively unimpaired individuals at risk for autosomal dominant AD.
- To examine the association between religious stress coping and brain pathology, specifically entorhinal tau, in this population.
Main Methods
- Study population: Cognitively unimpaired individuals from a Colombian kindred with autosomal dominant AD (Presenilin-1 E280A mutation carriers and non-carriers).
- Assessment of religious stress coping strategies.
- Measurement of memory performance.
- Quantification of brain pathology using neuroimaging (entorhinal tau).
Main Results
- Religious coping was significantly associated with lower entorhinal tau levels (p=0.02) in Presenilin-1 E280A mutation carriers.
- Religious coping was also linked to better memory performance (p=0.04) in mutation carriers.
- These associations were not observed in non-carriers.
Conclusions
- Religious coping may serve as a protective factor against Alzheimer's disease pathology and cognitive decline in individuals with a genetic predisposition.
- Findings suggest that religious coping might mitigate the effects of AD-related tau pathology.
- Further research is warranted to confirm these findings and explore the underlying mechanisms.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...